Simplify Asset Management »

Leap Therapeutics shares owned by Simplify Asset Management

Quarter-by-quarter ownership of Leap Therapeutics (LPTX) shares owned by Simplify Asset Management from 13F filings

Historical chart of Simplify Asset Management investment in Leap Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Leap Therapeutics held by Simplify Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Leap Therapeutics by Simplify Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $2.7M 1.1M 2.57
2024-06-30 $1.2M 631k 1.96
2024-03-31 $1.0M 376k 2.66

More positions owned by Simplify Asset Management

Spdr Gold Tr Gold Shs Put Option (GLD)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core Us Aggbd Et (AGG)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Simplify Exchange Traded Fun Aggregate Bond E (AGGH)
Simplify Exchange Traded Fun Stable Incm Etf (BUCK)
Simplify Exchange Traded Fun Natl Muni Bd Etf
Simplify Exchange Traded Fun Intmd Term Trsry (TYA)
Simplify Exchange Traded Fun Mbs Etf (MTBA)
Schwab Strategic Tr Us Tips Etf (SCHP)
Simplify Exchange Traded Fun High Yield Plus (CDX)
Pimco Etf Tr Enhan Shrt Ma Ac (MINT)
J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)
Sarepta Therapeutics (SRPT)
Applied Therapeutics (APLT)

View all positions for Simplify Asset Management

Top funds holding Leap Therapeutics

Balyasny Asset Management
Samsara BioCapital
683 Capital Management
Rock Springs Capital Management
Baker Bros. Advisors
Simplify Asset Management
Vanguard Group
Laurion Capital Management
Citadel Advisors
Geode Capital Management
Key Client Fiduciary Advisors
BlackRock
Acadian Asset Management
BlackRock
Exome Asset Management

View all funds holding Leap Therapeutics